+8,217.7%
EOG vs GSK
+1,733.0%
+6,484.7%
-77.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.2% | +0.1% | +1.1% | +1.2% |
| 7D | +7.4% | +0.5% | +6.9% | +7.3% |
| 30D | +2.3% | +9.4% | -7.2% | -0.3% |
| 3M | +9.5% | +1.6% | +7.9% | +8.6% |
| 6M | +17.7% | +1.3% | +16.4% | +16.5% |
| YTD | +52.9% | +6.0% | +46.9% | +48.6% |
| 1Y | +47.7% | +9.1% | +38.6% | +42.3% |
| 3Y | +41.1% | +65.4% | -24.3% | +18.7% |
| 5Y | +108.2% | +43.0% | +65.2% | +80.3% |
| 10Y | +136.3% | +103.1% | +33.2% | +84.3% |
| All | +8,217.7% | +1,733.0% | +6,484.7% | +4,929.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling